Live Breaking News & Updates on Elafibranor Slows Disease Progression

Stay updated with breaking news from Elafibranor slows disease progression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Grants Accelerated Approval to Elafibranor (Iqirvo) for PBC

The accelerated approval is based on data from the phase 3 ELATIVE trial demonstrating a reduction in alkaline phosphatase with elafibranor. ....

United Kingdom , United States , Kris Kowdley , Christelle Huguet , Ipsen Iqirvo , Liver Institute , Healthcare Products Regulatory Authority , Drug Administration , European Medicines Agency , American Association , Liver Disease , Liver Institute Northwest , European Association , United Kingdom Medicines , Healthcare Products Regulatory , Breakthrough Therapy Designation , New Drug Application , Prescription Drug User Fee Act , New England Journal , Elafibranor Slows Disease Progression , Improves Itch Related Qol ,